视觉肥胖和HFpEF:目标和治疗机会
Yilin Li1, Zhuofeng Lin2, Yulin Li1
1Beijing Anzhen Hospital, Capital Medical University, Key Laboratory of the Ministry of Education for Cardiovascular Remodeling-Related Diseases, Beijing Collaborative Innovative Research Center for Cardiovascular Diseases, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China.
Trends in pharmacological sciences
|March 20, 2025
概括
减肥药物显示出对心力衰竭与保留喷射分数 (HFpEF) 的承诺,强调了肥胖和心脏病之间的联系. 了解内脏肥胖症的理解
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 肥胖问题研究研究
背景情况:
- 减肥药物在心力衰竭中表现出有效性,具有保存的喷射分数 (HFpEF).
- 越来越多的证据将肥胖,特别是内脏脂肪,与心血管健康联系在一起.
- 腰与身高的比率越来越多地用于评估肥胖和指导治疗.
研究的目的:
- 阐明内脏肥胖和HFpEF之间的复杂关系.
- 介绍和探索"内脏脂肪组织-心脏轴"概念.
- 确定与肥胖相关的HFpEF的新疗法策略.
主要方法:
- 审查和综合目前关于肥胖和HFpEF的研究.
- 对内脏脂肪组织-心脏轴的概念框架开发.
- 讨论现有和潜在的治疗干预措施.
主要成果:
- 这项研究阐明了过多的内脏脂肪与HFpEF病理生理学之间的联系.
- 内脏脂肪组织-心脏轴为了解疾病机制提供了一个框架.
- 针对内脏肥胖症的新兴治疗方法显示了HFpEF的治疗潜力.
结论:
- 内脏肥胖是一个重要的,但未被充分研究的HFpEF因素.
- 向内脏脂肪组织为新型HFpEF治疗提供了一个有希望的途径.
- 对内脏脂肪组织-心脏轴的进一步研究是有必要的.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
119
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
119
Cholesterol: Significance and Regulation
483
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
483
Ultrasound II: Endoscopic Ultrasound and FibroScan
62
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
62


